Chinese biopharmaceutical innovator Mabwell has announced a major milestone in its oncology pipeline: its proprietary CDH17-targeting antibody-drug...
News
Global medical technology leader Demetra has announced the launch of its new spine-focused division, Demetra Spine, following...
A groundbreaking multi-institutional study has uncovered a hidden mechanism potentially responsible for the high recurrence rate in...
In a promising turn for brain cancer research, funding for glioblastoma (GBM) has seen a significant uptick,...
Seoul, South Korea Lotte Biologics is making significant strides in expanding its global presence in the Contract...
Azenta Life Sciences and Frenova, a division of Fresenius Medical Care and a leader in renal precision...
Zenara Pharma Private Limited, a leading Biophore company, has received final approval from the U.S. Food and...
Silexion Therapeutics Corp., a global clinical-stage biotech company specializing in RNA interference (RNAi) therapies, has announced outstanding...
Canada and the UK have joined forces in a groundbreaking project aimed at developing next-generation immunotherapies for...
Xenetic Biosciences, Inc., a biopharmaceutical company pioneering in immuno-oncology, has entered into a clinical study agreement with...
